Growth Metrics

HNO International (HNOI) EBIAT (2022 - 2026)

HNO International filings provide 5 years of EBIAT readings, the most recent being -$182069.0 for Q1 2026.

  • On a quarterly basis, EBIAT rose 96.67% to -$182069.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$1.3 million, a 83.89% increase, with the full-year FY2025 number at -$6.6 million, down 98.15% from a year prior.
  • EBIAT hit -$182069.0 in Q1 2026 for HNO International, up from -$186027.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$182069.0 in Q1 2026 to a low of -$5.5 million in Q1 2025.
  • Median EBIAT over the past 5 years was -$470066.0 (2025), compared with a mean of -$847507.0.
  • Biggest five-year swings in EBIAT: tumbled 977.04% in 2025 and later soared 96.67% in 2026.
  • HNO International's EBIAT stood at -$278426.0 in 2022, then plummeted by 246.76% to -$965466.0 in 2023, then tumbled by 82.82% to -$1.8 million in 2024, then surged by 89.46% to -$186027.0 in 2025, then increased by 2.13% to -$182069.0 in 2026.
  • The last three reported values for EBIAT were -$182069.0 (Q1 2026), -$186027.0 (Q4 2025), and -$498010.0 (Q3 2025) per Business Quant data.